FORTREA HOLDINGS INC. Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted
FORTREA HOLDINGS INC. (FTRE) reported Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted of -$271.50 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Income Statement › Other Income
us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted · last filed 2025-03-03
- FORTREA HOLDINGS INC. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2024-12-31 was -$73.90M.
- FORTREA HOLDINGS INC. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2024-09-30 was -$18.50M.
- FORTREA HOLDINGS INC. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2024-06-30 was -$99.30M, a 497.20% decline year-over-year.
- FORTREA HOLDINGS INC. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2024-03-31 was -$79.80M, a 1097.50% decline year-over-year.
- FORTREA HOLDINGS INC. net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2024 was -$271.50M.
- FORTREA HOLDINGS INC. net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2023 was -$31.70M, a 121.73% decline from fiscal 2022.
- FORTREA HOLDINGS INC. net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2022 was $145.90M.
| Period end | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 3 month | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 6 month | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 9 month | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$73.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$92.40M derived: sum of 2 quarters · filed 2025-03-03 | -$191.70M derived: sum of 3 quarters · filed 2025-03-03 | -$271.50M 10-K · filed 2025-03-03 |
| 2024-09-30 | -$18.50M 10-Q · filed 2024-11-08 | -$117.80M derived: sum of 2 quarters · filed 2024-11-08 | -$197.60M 10-Q · filed 2024-11-08 | -$246.20M derived: sum of 4 quarters · filed 2025-03-03 |
| 2024-06-30 | -$99.30M 10-Q · filed 2024-08-12 | -$179.10M 10-Q · filed 2024-08-12 | -$227.70M derived: sum of 3 quarters · filed 2025-03-03 | -$243.80M derived: sum of 4 quarters · filed 2025-03-03 |
| 2024-03-31 | -$79.80M 10-Q · filed 2024-05-24 | -$128.40M derived: sum of 2 quarters · filed 2025-03-03 | -$144.50M derived: sum of 3 quarters · filed 2025-03-03 | -$119.50M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-12-31 | -$48.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$64.70M derived: sum of 2 quarters · filed 2025-03-03 | -$39.70M derived: sum of 3 quarters · filed 2025-03-03 | -$31.70M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$16.10M 10-Q · filed 2024-11-08 | $8.90M derived: sum of 2 quarters · filed 2024-11-08 | $16.90M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $25.00M 10-Q · filed 2024-08-12 | $33.00M 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | $8.00M 10-Q · filed 2024-05-24 | |||
| 2022-12-31 | $145.90M 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |